Surface Oncology, Inc. Common Stock
SURF
SURF was delisted on the 7th of September, 2023.
29 hedge funds and large institutions have $25.5M invested in Surface Oncology, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 13 reducing their positions, and 8 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2% less capital invested
Capital invested by funds: $26.1M → $25.5M (-$554K)
15% less funds holding
Funds holding: 34 → 29 (-5)
46% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 13
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
+$497K |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$70.7K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$64.7K |
| 4 |
MWM
Mission Wealth Management
Santa Barbara,
California
|
+$26.4K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$12.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$272K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$164K |
| 3 |
Squarepoint
New York
|
-$107K |
| 4 |
BlackRock
New York
|
-$100K |
| 5 |
RC
RBF Capital
San Francisco,
California
|
-$88K |
SURF Hedge Fund Activity: Q1 2020 in Review
29 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in Surface Oncology, Inc. Common Stock (SURF) for Q1 2020, worth a combined $25.5M — down 2.1% from $26.1M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of SURF and 3 opened new positions — a net loss of 5 holders — while 13 trimmed existing stakes and 7 added.
The largest buyer was Victory Capital Management, adding an estimated $497K. The largest seller was BVF Inc, cutting an estimated $272K.
- 29 institutional investors held Surface Oncology, Inc. Common Stock (SURF) as of Q1 2020, down from 34 in Q4 2019.
- Funds reported $25.5M of Surface Oncology, Inc. Common Stock stock for Q1 2020, down 2.1% quarter-over-quarter.
- 3 funds opened new Surface Oncology, Inc. Common Stock positions in Q1 2020 and 8 closed out, a net change of -5 holders.
- The largest Surface Oncology, Inc. Common Stock buyer in Q1 2020 was Victory Capital Management, an estimated $497K added.
- The largest Surface Oncology, Inc. Common Stock seller in Q1 2020 was BVF Inc, an estimated $272K sold.
Based on aggregated 13F filings for Q1 2020.